home / stock / elox / elox short
Short Information | Eloxx Pharmaceuticals Inc. (NASDAQ:ELOX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 99,139 |
Total Actual Volume | 444,216 |
Short Trends | |
---|---|
Cover Days | 17 |
Short Days | 1 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 4,957 |
Average Short Percentage | 21.31% |
Is there a ELOX Short Squeeze or Breakout about to happen?
See the ELOX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
10-13-2023 | $4.05 | $3.82 | $4.29 | $3.79 | 45,132 | 23,418 | 51.89% |
10-12-2023 | $4.23 | $4.05 | $4.245 | $3.91 | 28,162 | 3,610 | 12.82% |
10-11-2023 | $4.4 | $4.15 | $4.4 | $4.1 | 12,523 | 3,882 | 31% |
10-10-2023 | $4.39 | $4.36 | $4.49 | $4.15 | 10,046 | 1,456 | 14.49% |
10-09-2023 | $4.3 | $4.4 | $4.48 | $4.2119 | 18,097 | 5,502 | 30.4% |
10-06-2023 | $4.46 | $4.32 | $4.53 | $4.2 | 25,935 | 8,270 | 31.89% |
10-05-2023 | $4.74 | $4.51 | $4.74 | $4.51 | 5,037 | 1,179 | 23.41% |
10-04-2023 | $4.66 | $4.58 | $5.09 | $4.5301 | 39,988 | 2,464 | 6.16% |
10-03-2023 | $4.51 | $4.78 | $5.18 | $4.51 | 32,489 | 3,568 | 10.98% |
10-02-2023 | $4.68 | $4.76 | $4.8 | $4.6 | 3,938 | 504 | 12.8% |
09-29-2023 | $4.78 | $4.81 | $5 | $4.69 | 16,515 | 1,594 | 9.65% |
09-28-2023 | $4.99 | $4.63 | $5.0194 | $4.63 | 14,949 | 7,356 | 49.21% |
09-27-2023 | $4.97 | $4.92 | $5.1789 | $4.8992 | 8,909 | 423 | 4.75% |
09-26-2023 | $4.78 | $4.94 | $5.2 | $4.78 | 24,198 | 3,558 | 14.7% |
09-25-2023 | $4.98 | $4.84 | $5.4616 | $4.71 | 16,300 | 4,013 | 24.62% |
09-22-2023 | $4.86 | $5.02 | $5.245 | $4.86 | 11,500 | 4,546 | 39.53% |
09-21-2023 | $5.42 | $4.86 | $5.4899 | $4.66 | 42,914 | 14,582 | 33.98% |
09-20-2023 | $5.4 | $5.53 | $5.62 | $5.3 | 10,406 | 589 | 5.66% |
09-19-2023 | $5.45 | $5.55 | $5.55 | $5.2732 | 20,836 | 955 | 4.58% |
09-18-2023 | $5.99 | $5.46 | $5.99 | $5.26 | 56,342 | 7,670 | 13.61% |
News, Short Squeeze, Breakout and More Instantly...
Eloxx Pharmaceuticals Inc. Company Name:
ELOX Stock Symbol:
NASDAQ Market:
Eloxx Pharmaceuticals Inc. Website:
First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential treatment of rare dermatological and other diseases associated with nonsense mutations Positive written FDA feedback and guidance from a pre-Investigational New Drug Application (PI...
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for Q1 2024 ContraFect Corporation (CFRXQ) is expected to report for Q1 2024 American Clean Resources Group Inc (ACRG) is expected to report for Q1 2024 Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report f...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...